UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Lack of Ability to Present Antigens on Major Histocompatibility Complex Class II Molecules Aggravates Atherosclerosis in ApoE−/− Mice

Circulation (New York, N.Y.), 2019-05, Vol.139 (22), p.2554-2566

2019

Volltextzugriff (PDF)

Tolerogenic dendritic cells generated in vitro using a novel protocol mimicking mucosal tolerance mechanisms represent a potential therapeutic cell platform for induction of immune tolerance

Frontiers in immunology, 2023, Vol.14, p.1045183-1045183

2023

Volltextzugriff (PDF)

FADD, Caspase-3, and Caspase-8 and Incidence of Coronary Events

Arteriosclerosis, thrombosis, and vascular biology, 2017-05, Vol.37 (5), p.983

2017

Volltextzugriff (PDF)

Elevated Markers of Death Receptor-Activated Apoptosis are Associated with Increased Risk for Development of Diabetes and Cardiovascular Disease

EBioMedicine, 2017-12, Vol.26 (C), p.187-197

2017

Volltextzugriff (PDF)

Inhibition of nuclear factor of activated T-cells (NFAT) suppresses accelerated atherosclerosis in diabetic mice

PloS one, 2013-06, Vol.8 (6), p.e65020

2013

Volltextzugriff (PDF)

CD8+ T cell activation predominate early immune responses to hypercholesterolemia in Apoe⁻(/)⁻ mice

BMC immunology, 2010-12, Vol.11 (1), p.58-58, Article 58

2010

Volltextzugriff (PDF)

Recent advances on CD4+ T cells in atherosclerosis and its implications for therapy

European journal of pharmacology, 2017-12, Vol.816, p.58-66

2017

Volltextzugriff (PDF)

Nuclear Factor of Activated T Cells Is Activated in the Endothelium of Retinal Microvessels in Diabetic Mice

Journal of Diabetes Research, 2015-01, Vol.2015, p.428473-14

2015

Volltextzugriff (PDF)

Lymphocytes in atherosclerosis

Clinica chimica acta, 2012-10, Vol.413 (19-20), p.1562-1568

2012

Volltextzugriff (PDF)

T-helper 2 immunity is associated with reduced risk of myocardial infarction and stroke

Arteriosclerosis, thrombosis, and vascular biology, 2013-03, Vol.33 (3), p.637

2013

Volltextzugriff (PDF)

Low levels of circulating CD4+FoxP3+ T cells are associated with an increased risk for development of myocardial infarction but not for stroke

Arteriosclerosis, thrombosis, and vascular biology, 2012-08, Vol.32 (8), p.2000

2012

Volltextzugriff (PDF)

Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis

Atherosclerosis, 2018-03, Vol.270, p.1-7

2018

Volltextzugriff (PDF)

Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine

Journal of internal medicine, 2011-05, Vol.269 (5), p.546-556

2011

Volltextzugriff (PDF)

Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus

Vascular pharmacology, 2021-10, Vol.140, p.106863-106863, Article 106863

2021

Volltextzugriff (PDF)

Treatment with a GnRH receptor agonist, but not the GnRH receptor antagonist degarelix, induces atherosclerotic plaque instability in ApoE(-/-) mice

Scientific reports, 2016-05, Vol.6 (1), p.26220-26220, Article 26220

2016

Volltextzugriff (PDF)

Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular disease

Diabetes & vascular disease research, 2019-05, Vol.16 (3), p.270-280

2019

Volltextzugriff (PDF)

Pathogenic immunity in systemic lupus erythematous and atherosclerosis: common mechanisms and possible targets for intervention

Journal of internal medicine, 2015-11, Vol.278 (5), p.494-506

2015

Volltextzugriff (PDF)

IL-22 affects smooth muscle cell phenotype and plaque formation in apolipoprotein E knockout mice

Atherosclerosis, 2015-10, Vol.242 (2), p.506-514

2015

Volltextzugriff (PDF)

Vaccines against atherosclerosis

Expert review of vaccines, 2013-03, Vol.12 (3), p.311-321

2013

Volltextzugriff (PDF)

Decreased levels of stem cell factor in subjects with incident coronary events

Journal of internal medicine, 2016-02, Vol.279 (2), p.180-191

2016

Volltextzugriff (PDF)

B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice

Vascular pharmacology, 2018-12, Vol.111, p.54-61

2018

Volltextzugriff (PDF)

Vaccines against atherosclerosis: Therapeutic Vaccines and Immunotherapies: Current Challenges and New Frontiers

Expert review of vaccines, 2013, Vol.12 (3), p.311-321

2013

Volltextzugriff (PDF)

Regulatory T Cells and the Control of Modified Lipoprotein Autoimmunity-Driven Atherosclerosis

Trends in cardiovascular medicine, 2009-11, Vol.19 (8), p.272-276

2009

Volltextzugriff (PDF)

High plasma levels of heparin-binding epidermal growth factor are associated with a more stable plaque phenotype and reduced incidence of coronary events

Arteriosclerosis, thrombosis, and vascular biology, 2015-01, Vol.35 (1), p.222

2015

Volltextzugriff (PDF)

CD4+CD56+ natural killer T‐like cells secreting interferon‐γ are associated with incident coronary events

Journal of internal medicine, 2016-01, Vol.279 (1), p.78-88

2016

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(51)

Publikationsform

Sprache

Englisch
(55)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lack of Ability to Present Antigens on Major Histocompatibility Complex Class II Molecules Aggravates Atherosclerosis in ApoE−/− Mice

Tolerogenic dendritic cells generated in vitro using a novel protocol mimicking mucosal tolerance mechanisms represent a potential therapeutic cell platform for induction of immune tolerance

FADD, Caspase-3, and Caspase-8 and Incidence of Coronary Events

Elevated Markers of Death Receptor-Activated Apoptosis are Associated with Increased Risk for Development of Diabetes and Cardiovascular Disease

Inhibition of nuclear factor of activated T-cells (NFAT) suppresses accelerated atherosclerosis in diabetic mice

CD8+ T cell activation predominate early immune responses to hypercholesterolemia in Apoe⁻(/)⁻ mice

Recent advances on CD4+ T cells in atherosclerosis and its implications for therapy

Nuclear Factor of Activated T Cells Is Activated in the Endothelium of Retinal Microvessels in Diabetic Mice

Lymphocytes in atherosclerosis

T-helper 2 immunity is associated with reduced risk of myocardial infarction and stroke

Low levels of circulating CD4+FoxP3+ T cells are associated with an increased risk for development of myocardial infarction but not for stroke

Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis

Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine

Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus

Treatment with a GnRH receptor agonist, but not the GnRH receptor antagonist degarelix, induces atherosclerotic plaque instability in ApoE(-/-) mice

Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular disease

Pathogenic immunity in systemic lupus erythematous and atherosclerosis: common mechanisms and possible targets for intervention

IL-22 affects smooth muscle cell phenotype and plaque formation in apolipoprotein E knockout mice

Vaccines against atherosclerosis

Decreased levels of stem cell factor in subjects with incident coronary events

B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice

Vaccines against atherosclerosis: Therapeutic Vaccines and Immunotherapies: Current Challenges and New Frontiers

Regulatory T Cells and the Control of Modified Lipoprotein Autoimmunity-Driven Atherosclerosis

High plasma levels of heparin-binding epidermal growth factor are associated with a more stable plaque phenotype and reduced incidence of coronary events

CD4+CD56+ natural killer T‐like cells secreting interferon‐γ are associated with incident coronary events

Suchergebnisse filtern